BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34758846)

  • 1. Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses.
    Tanha K; Mottaghi A; Nojomi M; Moradi M; Rajabzadeh R; Lotfi S; Janani L
    J Ovarian Res; 2021 Nov; 14(1):153. PubMed ID: 34758846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.
    Xiong Y; Bian C; Lin X; Wang X; Xu K; Zhao X
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32639550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between MTHFR gene polymorphism and the risk of ovarian cancer: a meta-analysis of the literature.
    Pu D; Jiang SW; Wu J
    Curr Pharm Des; 2014; 20(11):1632-8. PubMed ID: 24720627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.
    Ma C; Liu Y; Zhang W; Liu P
    Mol Biol Rep; 2013 Mar; 40(3):2061-8. PubMed ID: 23329275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of MTHFR 677C>T Polymorphism with Susceptibility to Ovarian and Cervical Cancers: A Systematic Review and Meta-Analysis.
    Karimi-Zarchi M; Moghimi M; Abbasi H; Hadadan A; Salimi E; Morovati-Sharifabad M; Akbarian-Bafghi MJ; Zare-Shehneh M; Mosavi-Jarrahi A; Neamatzadeh H
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2569-2577. PubMed ID: 31554347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do genetic polymorphisms of the vitamin D receptor contribute to breast/ovarian cancer? A systematic review and network meta-analysis.
    Li J; Li B; Jiang Q; Zhang Y; Liu A; Wang H; Zhang J; Qin Q; Hong Z; Li BA
    Gene; 2018 Nov; 677():211-227. PubMed ID: 30059751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTHFR polymorphisms and ovarian cancer risk: a meta-analysis.
    Liu L; Liao SG; Wang YJ
    Mol Biol Rep; 2012 Nov; 39(11):9863-8. PubMed ID: 22810649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate intake and MTHFR polymorphism C677T is not associated with ovarian cancer risk: evidence from the meta-analysis.
    Li C; Chen P; Hu P; Li M; Li X; Guo H; Li J; Chu R; Zhang W; Wang H
    Mol Biol Rep; 2013 Dec; 40(12):6547-60. PubMed ID: 24129496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the MTHFR C677T Polymorphism as a Risk Factor for Colorectal Cancer in Asian Populations.
    Rai V
    Asian Pac J Cancer Prev; 2015; 16(18):8093-100. PubMed ID: 26745044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis.
    Ding XP; Feng L; Ma L
    Asian Pac J Cancer Prev; 2012; 13(8):3937-42. PubMed ID: 23098496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet and ovarian cancer risk: An umbrella review of systematic reviews and meta-analyses of cohort studies.
    Sun H; Gong TT; Xia Y; Wen ZY; Zhao LG; Zhao YH; Wu QJ
    Clin Nutr; 2021 Apr; 40(4):1682-1690. PubMed ID: 33308841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTHFR A1298C polymorphism and ovarian cancer risk: a meta-analysis.
    Shi XY; Shen Q
    Genet Mol Res; 2015 Jul; 14(3):8211-8. PubMed ID: 26345746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental and Genetic Risk Factors of Congenital Anomalies: an Umbrella Review of Systematic Reviews and Meta-Analyses.
    Lee KS; Choi YJ; Cho J; Lee H; Lee H; Park SJ; Park JS; Hong YC
    J Korean Med Sci; 2021 Jul; 36(28):e183. PubMed ID: 34282604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopausal hormone therapy and women's health: An umbrella review.
    Zhang GQ; Chen JL; Luo Y; Mathur MB; Anagnostis P; Nurmatov U; Talibov M; Zhang J; Hawrylowicz CM; Lumsden MA; Critchley H; Sheikh A; Lundbäck B; Lässer C; Kankaanranta H; Lee SH; Nwaru BI
    PLoS Med; 2021 Aug; 18(8):e1003731. PubMed ID: 34339416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASSOCIATION OF MTHFR A1298C POLYMORPHISM WITH BREAST CANCER AND/OR OVARIAN CANCER RISK: AN UPDATED META-ANALYSIS.
    Liu W; Li Y; Li R; Han X; Ma Y; Liu B; Kong X
    Afr J Tradit Complement Altern Med; 2016; 13(5):72-86. PubMed ID: 28487897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perineal Talc Use and Ovarian Cancer: A Systematic Review and Meta-Analysis.
    Penninkilampi R; Eslick GD
    Epidemiology; 2018 Jan; 29(1):41-49. PubMed ID: 28863045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D receptor gene polymorphisms and the risk for female reproductive cancers: A meta-analysis.
    Mun MJ; Kim TH; Hwang JY; Jang WC
    Maturitas; 2015 Jun; 81(2):256-65. PubMed ID: 25882760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
    Salvador S; Scott S; Francis JA; Agrawal A; Giede C
    J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee.
    Whittemore AS; Wu ML; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M
    Am J Epidemiol; 1988 Dec; 128(6):1228-40. PubMed ID: 3195564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.